Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Optimizing the Care Pathways of Patients Treated for Operable Breast. (OPTIsoins01)

12. april 2017 oppdatert av: Institut Curie

Optimizing the Care Pathways of Patients Treated for Operable Breast Cancer

This prospective, multicenter, observational study aims to explore a comprehensive approach to the care of early breast cancer patients in a regional health territory (including 1.5 million women and characterized by a breast cancer incidence and mortality higher than national ranges), incorporating all healthcare actors inside and outside the hospital.

Studieoversikt

Status

Fullført

Detaljert beskrivelse

The treatment course of a breast cancer patient includes a hospital stay, home health care that requires outpatient services, supportive care and a follow-up course. Outpatient surgery and home hospitalization units are two innovative organizational technologies that are strongly recommended because of their putative positive medico-economic impact; however, these structures are poorly studied in terms of quality of care and patient satisfaction. Regional implementation of these innovations is heterogeneous, thus allowing a comparative study.

This prospective, multicenter, observational study aims to explore a comprehensive approach to the care of early breast cancer patients in a regional health territory (including 1.5 million women and characterized by a breast cancer incidence and mortality higher than national ranges), incorporating all healthcare actors inside and outside the hospital.

This study will be conducted in academic centers, general hospitals and private centers. In the different participating centers, the implemented care steps are different and may include outpatient surgery, home hospitalization, a one-stop breast clinic visit, care by an oncology pivot nurse and/or screening for supportive care. Outpatient surgery and home hospitalization in particular are two health technologies that are validated by the French National Authority for Health but used differently in different centers.

The primary objective is to examine the economic and financial measurements of the different care pathways of early breast cancer patients to compare the economic burden of outpatient surgery and home hospitalization with the conventional care pathway.

The secondary objectives are:

Assessing patient satisfaction and needs for supportive care. Evaluating the structures and organizations. Evaluating the tool exchanges between the actors over the treatment course.

All parameters related to the patient and to disease characteristics, determinants and management characteristics within and outside the center within one year will be collected and centralized in the study database. The patients' course of care will be divided into five stages: preadmission, hospitalization, the postoperative period (+ 1 month), adjuvant treatments and one-year follow-up. Care pathways will be identified, described and analyzed to meet the primary objective and the secondary objectives.

After analyzing these care pathways, we will propose solutions for optimizing hospital and nonhospital care, thereby building efficient connections among the hospital, home health care, district nurse networks, medical and social sectors, and occupational reintegration.

Studietype

Observasjonsmessig

Registrering (Faktiske)

617

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

      • Argenteuil, Frankrike, 95100
        • Victor Dupouy Hospital
      • Clamart, Frankrike
        • Antoine Béclère Hospital
      • Colombes, Frankrike, 92700
        • Louis Mourier Hospital
      • Le Chesnay, Frankrike, 78150
        • André Mignot Hospital - Versailles
      • Paris, Frankrike, 75005
        • Institut Curie
      • Paris, Frankrike, 75018
        • Bichat Beaujon University Hospital
      • Poissy, Frankrike, 78300
        • Poissy Interegional Hospital Center
      • Pontoise, Frankrike, 95000
        • Rene Dubos Hospital
      • Saint-Cloud, Frankrike, 92210
        • Institut Curie - René Huguenin Hospital

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år og eldre (Voksen, Eldre voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Hunn

Prøvetakingsmetode

Ikke-sannsynlighetsprøve

Studiepopulasjon

Previously untreated, operable breast cancer.

Beskrivelse

Inclusion Criteria:

  1. Signed written informed consent.
  2. Patients aged ≥18 years.
  3. Previously untreated, operable breast cancer
  4. Affiliation with the social security system (or a similar coverage)
  5. Patient living in one of these french department : "Hauts-de-Seine (92)", "les Yvelines (78)", or "le Val d'Oise (95)".
  6. Female gender.

Exclusion Criteria:

  1. Previous history of breast cancer.
  2. Metastatic, locally advanced, or inflammatory breast cancer, as defined by the AJCC (American Joint Committee on Cancer, 7th Edition).
  3. Any prior treatment for primary breast cancer.
  4. Patient with any psychological, sociological or geographical condition potentially hampering compliance with the study follow-up schedule.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Observasjonsmodeller: Kohort
  • Tidsperspektiver: Potensielle

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Care pathways description of early breast cancer patients.
Tidsramme: Up to one year after patient registration
Care pathways will be characterized by the sequence of different care steps. Care steps may include : outpatient surgery, home hospitalization, a one-stop breast clinic visit, care by an oncology pivot nurse and/or screening for supportive care.
Up to one year after patient registration
Overall cost measurements of the different care pathways.
Tidsramme: Up to one year after patient registration
Evaluating the overall costs of the pathway care (health care and supportive care consumption) at one year for the different perspectives.
Up to one year after patient registration
Overall cost measurements of the different care pathways for health insurance
Tidsramme: Up to one year after patient registration
Evaluating the indirect costs of health insurance
Up to one year after patient registration
Overall cost measurements of the different care pathways for the patient
Tidsramme: Up to one year after patient registration
Evaluating the out-of-pocket health expenses for breast cancer during the first year post diagnosis (direct and indirect costs).
Up to one year after patient registration

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Patient satisfaction evaluation
Tidsramme: Up to one year after patient registration.
Patient satisfaction will be assessed at different time points using the OUT-PATSAT35 questionnaire validated in French.
Up to one year after patient registration.
Supportive care needs assessement
Tidsramme: Up to one year after patient registration
The patient's needs for supportive care will be assessed using the Supportive Care Needs Survey - Breast Cancer module (SCNS-BR8) validated in French.
Up to one year after patient registration
Supportive care needs assessement
Tidsramme: Up to one year after patient registration
The patient's needs for supportive care will be assessed using the Supportive Care Needs Survey Short Form (SCNS-SF34) validated in French.
Up to one year after patient registration
Breast cancer impact on patient's professional activity
Tidsramme: Up to one year after patient registration.
Evaluating patient return to work : Existence of an occupational reintegration or not.
Up to one year after patient registration.
Breast cancer impact on patient's professional activity
Tidsramme: Up to one year after patient registration.
Evaluating patient return to work : Date of return to work
Up to one year after patient registration.
Breast cancer impact on patient's professional activity
Tidsramme: Up to one year after patient registration.
Evaluating patient return to work : Organization of working time description
Up to one year after patient registration.
Breast cancer impact on patient's professional activity
Tidsramme: Up to one year after patient registration.
Evaluating patient return to work : Number of days out of work
Up to one year after patient registration.
Structures and organizations interactions description
Tidsramme: Up to one year after patient registration
Identification of health care actors inside and outside the hospital
Up to one year after patient registration
Structures and organizations interactions description
Tidsramme: Up to one year after patient registration
identification of the interactions between the organizations (e.g., identification, shared tools, resource sharing and nurse training).
Up to one year after patient registration
Structures and organizations interactions description
Tidsramme: Up to one year after patient registration
Regular practitioners questionnaires
Up to one year after patient registration

Andre resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Care pathways suggestion for a regional health territory.
Tidsramme: Through study completion (within one year after the last patient follow-up)
After analyzing these care pathways, we will propose solutions for optimizing hospital and nonhospital care, thereby building efficient connections among the hospital, home health care, district nurse networks, medical and social sectors, and occupational reintegration.
Through study completion (within one year after the last patient follow-up)

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Sponsor

Etterforskere

  • Studieleder: Roman ROUZIER, Pr, Institut Curie
  • Studieleder: Delphine HEQUET, MD PhD, Institut Curie

Publikasjoner og nyttige lenker

Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

1. desember 2014

Primær fullføring (Faktiske)

1. februar 2017

Studiet fullført (Faktiske)

1. april 2017

Datoer for studieregistrering

Først innsendt

6. januar 2016

Først innsendt som oppfylte QC-kriteriene

21. juni 2016

Først lagt ut (Anslag)

27. juni 2016

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

13. april 2017

Siste oppdatering sendt inn som oppfylte QC-kriteriene

12. april 2017

Sist bekreftet

1. april 2017

Mer informasjon

Begreper knyttet til denne studien

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere